Technology for
physiotherapy delivery in the ICU to prevent ICU-acquired weakness
What is ICU-acquired weakness
Muscle at ICU admission (light grey)
Same muscle 6 months post-ICU discharge
Patients ventilated and sedated in the ICU are most at risk of developing ICU-acquired weakness. Muscle loss can progress as quickly as 2-4% per day. 50% of patients 65 or older, on a ventilator in the ICU for a week or more experience permanent disability.
Improving Physical Therapy
Delivery in the ICU
About Us
Elaya develops solutions that enable neuromuscular electrical stimulation therapy in the ICU to prevent ICUAW, improve patient outcomes and post-ICU quality of life.
These innovations enable effective therapy delivery to multiple patients in the ICU and provide valuable insights for evidence-based personalized care.